These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20882255)

  • 61. Selective cytotoxic Ru(II) arene Cp* complex salts [R-PhRuCp*](+)X(-) for X = BF4(-), PF6(-), and BPh4(-).
    Loughrey BT; Healy PC; Parsons PG; Williams ML
    Inorg Chem; 2008 Oct; 47(19):8589-91. PubMed ID: 18783214
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes.
    Liu J; Zheng W; Shi S; Tan C; Chen J; Zheng K; Ji L
    J Inorg Biochem; 2008 Feb; 102(2):193-202. PubMed ID: 17825915
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New half sandwich Ru(II) coordination compounds for anticancer activity.
    Bratsos I; Mitri E; Ravalico F; Zangrando E; Gianferrara T; Bergamo A; Alessio E
    Dalton Trans; 2012 Jun; 41(24):7358-71. PubMed ID: 22580919
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis, characterization and cytotoxicity of arene-ruthenium(ii) complexes with acylpyrazolones functionalized with aromatic groups in the acyl moiety.
    Marchetti F; Pettinari R; Di Nicola C; Pettinari C; Palmucci J; Scopelliti R; Riedel T; Therrien B; Galindo A; Dyson PJ
    Dalton Trans; 2018 Jan; 47(3):868-878. PubMed ID: 29255821
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity.
    Giovagnini L; Sitran S; Castagliuolo I; Brun P; Corsini M; Zanello P; Zoleo A; Maniero A; Biondi B; Fregona D
    Dalton Trans; 2008 Dec; (47):6699-708. PubMed ID: 19153618
    [TBL] [Abstract][Full Text] [Related]  

  • 66. pH and DNA luminescence switching, DNA photocleavage and cytotoxic properties of two thiophene-containing ruthenium(II) complexes.
    Zhao XL; Li ZS; Zhang AG; Liu P; Song XM; Wang KZ
    Eur J Med Chem; 2014 Nov; 87():10-22. PubMed ID: 25238290
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis, characterization and anticancer activity of gold(I) complexes that contain tri-tert-butylphosphine and dialkyl dithiocarbamate ligands.
    Altaf M; Monim-ul-Mehboob M; Seliman AA; Sohail M; Wazeer MI; Isab AA; Li L; Dhuna V; Bhatia G; Dhuna K
    Eur J Med Chem; 2015 May; 95():464-72. PubMed ID: 25841201
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity.
    Mulyana Y; Weber DK; Buck DP; Motti CA; Collins JG; Keene FR
    Dalton Trans; 2011 Feb; 40(7):1510-23. PubMed ID: 21218244
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties.
    Vergara E; Cerrada E; Clavel C; Casini A; Laguna M
    Dalton Trans; 2011 Nov; 40(41):10927-35. PubMed ID: 21904768
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
    Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation of new half sandwich ruthenium arene complexes with aminophosphines as potential chemotherapeutics.
    Aliende C; Pérez-Manrique M; Jalón FA; Manzano BR; Rodríguez AM; Cuevas JV; Espino G; Martínez MÁ; Massaguer A; González-Bártulos M; de Llorens R; Moreno V
    J Inorg Biochem; 2012 Dec; 117():171-88. PubMed ID: 23085598
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release.
    Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N
    Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anticancer activity of hydrogen-bond-stabilized half-sandwich Ru(II) complexes with heterocycles.
    Mitra R; Das S; Shinde SV; Sinha S; Somasundaram K; Samuelson AG
    Chemistry; 2012 Sep; 18(39):12278-91. PubMed ID: 22903299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.
    Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F
    Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.
    Huang H; Zhang P; Chen Y; Ji L; Chao H
    Dalton Trans; 2015 Sep; 44(35):15602-10. PubMed ID: 26245234
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines.
    Morais TS; Silva TJ; Marques F; Robalo MP; Avecilla F; Amorim Madeira PJ; Mendes PJ; Santos I; Garcia MH
    J Inorg Biochem; 2012 Sep; 114():65-74. PubMed ID: 22698866
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers.
    Li L; Wong YS; Chen T; Fan C; Zheng W
    Dalton Trans; 2012 Jan; 41(4):1138-41. PubMed ID: 22159211
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
    Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
    Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hetero-multinuclear ruthenium(III)/platinum(II) complexes that potentially exhibit both antimetastatic and antineoplastic properties.
    Anderson CM; Taylor IR; Tibbetts MF; Philpott J; Hu Y; Tanski JM
    Inorg Chem; 2012 Dec; 51(23):12917-24. PubMed ID: 23150984
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
    Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
    Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.